The branded generics market is experiencing sustained expansion as healthcare systems worldwide strive to balance cost containment with access to trusted, quality-assured medicines. The global branded generics market size was valued at USD 368.52 billion in 2024 and is expected to reach USD 683.63 billion by 2032, at a CAGR of 8.03% during the forecast...